RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
$3.04
2.36%
+0.07
Notify me if price changes either direction
Buy RXRX stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
1.6B
Enterprise value
983.8M
Trailing PE
-2.1111110846202
Forward PE
-3.1547754
PEG Ratio
0.03769841222536
Enterprise to EBITDA
-1.963
Enterprise to revenue
14.814
Price to book MRQ
1.5380632
Price to sales TTM
23.737558
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2026-03-31
Revenue (TTM)
66.4M
EBITDA
-501225984
Diluted EPS TTM
-1.16
Total Cash (MRQ)
654.5M
Current ratio (MRQ)
5.471
Operating Cash Flow (TTM)
-320952000
RXRX trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
July 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
